...
首页> 外文期刊>American Journal of Case Reports >A Novel Ventilatory Technique in Refractory Hypoxemic Respiratory Failure Secondary to Therapeutic Thoracentesis and Paracentesis
【24h】

A Novel Ventilatory Technique in Refractory Hypoxemic Respiratory Failure Secondary to Therapeutic Thoracentesis and Paracentesis

机译:一种新型通风技术,令人难治性脱氧呼吸衰竭,继发于治疗胸腔和腹腔探伤

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Patient: Male, 61-year-old Final Diagnosis: Hypoxemic respiratory failure ? reperfusion pulmonary edema Symptoms: Respiratory deterioration Medication: — Clinical Procedure: — Specialty: Critical Care Medicine Objective: Unusual or unexpected effect of treatment Background: MetaNeb ~(?) is a respiratory therapy modality that aims to effect clearance of airway secretions through chest physiotherapy. It typically is used in critically ill patients with bronchiectasis or copious secretions. However, it also expands lungs through a continuous positive expiratory pressure and continuous high-frequency oscillation, which has the benefit of increasing lung recruitment and improving oxygenation. Case Report: A 61-year-old male who had re-expansion pulmonary edema following a paracentesis and thoracentesis for cirrhosis, which caused a large unilateral pleural effusion. He required intubation and his hypoxemia was refractory to standard maximum ventilatory measures. A trial of continuous MetaNeb ~(?) acted as a noninvasive extracorporeal membrane oxygenation method, dramatically improving oxygenation and hypoxemia, normalizing the patient’s blood gas, and thus stabilizing him. Conclusions: MetaNeb ~(?) could potentially be used in other community hospitals that lack the capability for advanced ventilatory modes or in patients who are too unstable for transfer.
机译:病人:男,61岁的最终诊断:缺氧呼吸衰竭?再灌注肺水肿症状:呼吸劣化药物: - 临床手术: - 专业:关键护理医学目标:治疗不寻常或意外的效果背景:MetaneB〜(?)是一种呼吸治疗方式,旨在通过胸部物理治疗来清除气道分泌物。它通常用于患有支气管扩张或大量分泌物的危重病人。然而,它还通过连续的正呼气压力和连续高频振荡来扩展肺,这具有增加肺募集和改善氧合的益处。案例报告:一名61岁的男性,患有肺气囊胸腔胸腔的肺气囊后重新扩增肺水肿,这导致了大的单侧胸腔积液。他需要插管,他的低氧血症是标准最大通气措施的难治性。连续Metaneb〜(α)的试验作用为非侵入体体外膜氧合法,显着改善氧化和低氧血症,使患者的血液归一化,从而稳定他。结论:Metaneb〜(?)可能用于其他社区医院,缺乏高级通风模式或过于转移的患者的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号